Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 120

1.

Breast cancer: hormones and other risk factors.

Hulka BS, Moorman PG.

Maturitas. 2008 Sep-Oct;61(1-2):203-13; discussion 213.

PMID:
19434892
2.

Estrogen-plus-progestin use and mammographic density in postmenopausal women: Women's Health Initiative randomized trial.

McTiernan A, Martin CF, Peck JD, Aragaki AK, Chlebowski RT, Pisano ED, Wang CY, Brunner RL, Johnson KC, Manson JE, Lewis CE, Kotchen JM, Hulka BS; Women's Health Initiative Mammogram Density Study Investigators.

J Natl Cancer Inst. 2005 Sep 21;97(18):1366-76.

PMID:
16174858
3.

Self-reported urogenital symptoms in postmenopausal women: Women's Health Initiative.

Pastore LM, Carter RA, Hulka BS, Wells E.

Maturitas. 2004 Dec 10;49(4):292-303.

PMID:
15531125
4.

Accuracy of fetal growth indicators as surrogate measures of steroid hormone levels during pregnancy.

Peck JD, Hulka BS, Savitz DA, Baird D, Poole C, Richardson BE.

Am J Epidemiol. 2003 Feb 1;157(3):258-66.

PMID:
12543626
5.

Alcohol, tobacco and breast cancer--collaborative reanalysis of individual data from 53 epidemiological studies, including 58,515 women with breast cancer and 95,067 women without the disease.

Hamajima N, Hirose K, Tajima K, Rohan T, Calle EE, Heath CW Jr, Coates RJ, Liff JM, Talamini R, Chantarakul N, Koetsawang S, Rachawat D, Morabia A, Schuman L, Stewart W, Szklo M, Bain C, Schofield F, Siskind V, Band P, Coldman AJ, Gallagher RP, Hislop TG, Yang P, Kolonel LM, Nomura AM, Hu J, Johnson KC, Mao Y, De Sanjosé S, Lee N, Marchbanks P, Ory HW, Peterson HB, Wilson HG, Wingo PA, Ebeling K, Kunde D, Nishan P, Hopper JL, Colditz G, Gajalanski V, Martin N, Pardthaisong T, Silpisornkosol S, Theetranont C, Boosiri B, Chutivongse S, Jimakorn P, Virutamasen P, Wongsrichanalai C, Ewertz M, Adami HO, Bergkvist L, Magnusson C, Persson I, Chang-Claude J, Paul C, Skegg DC, Spears GF, Boyle P, Evstifeeva T, Daling JR, Hutchinson WB, Malone K, Noonan EA, Stanford JL, Thomas DB, Weiss NS, White E, Andrieu N, Brêmond A, Clavel F, Gairard B, Lansac J, Piana L, Renaud R, Izquierdo A, Viladiu P, Cuevas HR, Ontiveros P, Palet A, Salazar SB, Aristizabel N, Cuadros A, Tryggvadottir L, Tulinius H, Bachelot A, Lê MG, Peto J, Franceschi S, Lubin F, Modan B, Ron E, Wax Y, Friedman GD, Hiatt RA, Levi F, Bishop T, Kosmelj K, Primic-Zakelj M, Ravnihar B, Stare J, Beeson WL, Fraser G, Bullbrook RD, Cuzick J, Duffy SW, Fentiman IS, Hayward JL, Wang DY, McMichael AJ, McPherson K, Hanson RL, Leske MC, Mahoney MC, Nasca PC, Varma AO, Weinstein AL, Moller TR, Olsson H, Ranstam J, Goldbohm RA, van den Brandt PA, Apelo RA, Baens J, de la Cruz JR, Javier B, Lacaya LB, Ngelangel CA, La Vecchia C, Negri E, Marubini E, Ferraroni M, Gerber M, Richardson S, Segala C, Gatei D, Kenya P, Kungu A, Mati JG, Brinton LA, Hoover R, Schairer C, Spirtas R, Lee HP, Rookus MA, van Leeuwen FE, Schoenberg JA, McCredie M, Gammon MD, Clarke EA, Jones L, Neil A, Vessey M, Yeates D, Appleby P, Banks E, Beral V, Bull D, Crossley B, Goodill A, Green J, Hermon C, Key T, Langston N, Lewis C, Reeves G, Collins R, Doll R, Peto R, Mabuchi K, Preston D, Hannaford P, Kay C, Rosero-Bixby L, Gao YT, Jin F, Yuan JM, Wei HY, Yun T, Zhiheng C, Berry G, Cooper Booth J, Jelihovsky T, MacLennan R, Shearman R, Wang QS, Baines CJ, Miller AB, Wall C, Lund E, Stalsberg H, Shu XO, Zheng W, Katsouyanni K, Trichopoulou A, Trichopoulos D, Dabancens A, Martinez L, Molina R, Salas O, Alexander FE, Anderson K, Folsom AR, Hulka BS, Bernstein L, Enger S, Haile RW, Paganini-Hill A, Pike MC, Ross RK, Ursin G, Yu MC, Longnecker MP, Newcomb P, Bergkvist L, Kalache A, Farley TM, Holck S, Meirik O; Collaborative Group on Hormonal Factors in Breast Cancer.

Br J Cancer. 2002 Nov 18;87(11):1234-45.

6.

Steroid hormone levels during pregnancy and incidence of maternal breast cancer.

Peck JD, Hulka BS, Poole C, Savitz DA, Baird D, Richardson BE.

Cancer Epidemiol Biomarkers Prev. 2002 Apr;11(4):361-8.

7.

Breast cancer: hormones and other risk factors.

Hulka BS, Moorman PG.

Maturitas. 2001 Feb 28;38(1):103-13; discussion 113-6. Review.

PMID:
11311599
8.

Hormone-related factors and risk of breast cancer in relation to estrogen receptor and progesterone receptor status.

Huang WY, Newman B, Millikan RC, Schell MJ, Hulka BS, Moorman PG.

Am J Epidemiol. 2000 Apr 1;151(7):703-14.

PMID:
10752798
9.

Experience of a scientific panel formed to advise the federal judiciary on silicone breast implants.

Hulka BS, Kerkvliet NL, Tugwell P.

N Engl J Med. 2000 Mar 16;342(11):812-5. No abstract available.

PMID:
10717019
10.

Meta-analyses of the relation between silicone breast implants and the risk of connective-tissue diseases.

Janowsky EC, Kupper LL, Hulka BS.

N Engl J Med. 2000 Mar 16;342(11):781-90.

11.

Risk of breast cancer according to the status of HER-2/neu oncogene amplification.

Huang WY, Newman B, Millikan RC, Conway K, Hulka BS, Schell MJ, Liu ET.

Cancer Epidemiol Biomarkers Prev. 2000 Jan;9(1):65-71.

12.

HER-2/neu amplification in benign breast disease and the risk of subsequent breast cancer.

Stark A, Hulka BS, Joens S, Novotny D, Thor AD, Wold LE, Schell MJ, Melton LJ 3rd, Liu ET, Conway K.

J Clin Oncol. 2000 Jan;18(2):267-74.

PMID:
10637239
13.

Association between low levels of 1,25-dihydroxyvitamin D and breast cancer risk.

Janowsky EC, Lester GE, Weinberg CR, Millikan RC, Schildkraut JM, Garrett PA, Hulka BS.

Public Health Nutr. 1999 Sep;2(3):283-91.

PMID:
10512563
14.

Levels of maternal serum alpha-fetoprotein (AFP) in pregnant women and subsequent breast cancer risk.

Richardson BE, Hulka BS, Peck JL, Hughes CL, van den Berg BJ, Christianson RE, Calvin JA.

Am J Epidemiol. 1998 Oct 15;148(8):719-27.

PMID:
9786226
15.

Association between high-density lipoprotein cholesterol and breast cancer varies by menopausal status.

Moorman PG, Hulka BS, Hiatt RA, Krieger N, Newman B, Vogelman JH, Orentreich N.

Cancer Epidemiol Biomarkers Prev. 1998 Jun;7(6):483-8.

16.

Breast cancer survival and the timing of tumor removal during the menstrual cycle.

Chang S, Hulka BS, Baird DD, Ingle JN, Newman B, Graham ML 2nd, Qaqish B, Donohue JH, Melton LJ 3rd.

Cancer Epidemiol Biomarkers Prev. 1997 Nov;6(11):881-6.

17.

Epidemiologic analysis of breast and gynecologic cancers.

Hulka BS.

Prog Clin Biol Res. 1997;396:17-29. Review.

PMID:
9108587
19.

Research on the menopause.

Hulka BS, Meirik O.

Maturitas. 1996 Mar;23(2):109-12. Review. No abstract available.

PMID:
8735349
20.

Epidemiology of susceptibility to breast cancer.

Hulka BS.

Prog Clin Biol Res. 1996;395:159-74. Review.

PMID:
8895988
21.

Hormones and breast and endometrial cancers: preventive strategies and future research.

Hulka BS, Brinton LA.

Environ Health Perspect. 1995 Nov;103 Suppl 8:185-9. Review.

22.

Breast cancer: cause and prevention.

Hulka BS, Stark AT.

Lancet. 1995 Sep 30;346(8979):883-7. Review. No abstract available.

PMID:
7564675
23.

Ha-ras rare alleles in breast cancer susceptibility.

Conway K, Edmiston S, Fried DB, Hulka BS, Garrett PA, Liu ET.

Breast Cancer Res Treat. 1995 Jul;35(1):97-104.

PMID:
7612910
24.

Human tissue monitoring and specimen banking: opportunities for exposure assessment, risk assessment, and epidemiologic research.

Lee LW, Griffith J, Zenick H, Hulka BS.

Environ Health Perspect. 1995 Apr;103 Suppl 3:3-8. Review.

25.

Follicle-stimulating hormone concentrations in relation to active and passive smoking.

Cooper GS, Baird DD, Hulka BS, Weinberg CR, Savitz DA, Hughes CL Jr.

Obstet Gynecol. 1995 Mar;85(3):407-11.

PMID:
7862381
26.

Links between hormone replacement therapy and neoplasia.

Hulka BS.

Fertil Steril. 1994 Dec;62(6 Suppl 2):168S-175S. Review.

PMID:
7958013
27.

Galactose consumption, metabolism, and follicle-stimulating hormone concentrations in women of late reproductive age.

Cooper GS, Hulka BS, Baird DD, Savitz DA, Hughes CL Jr, Weinberg CR, Coleman RA, Shields JM.

Fertil Steril. 1994 Dec;62(6):1168-75.

PMID:
7957979
28.

Steroid hormones and risk of breast cancer.

Hulka BS, Liu ET, Lininger RA.

Cancer. 1994 Aug 1;74(3 Suppl):1111-24. Review.

PMID:
8039146
29.

Risk factors for menopausal hot flashes.

Schwingl PJ, Hulka BS, Harlow SD.

Obstet Gynecol. 1994 Jul;84(1):29-34.

PMID:
8008318
30.

Cigarette smoking and sperm density: a meta-analysis.

Vine MF, Margolin BH, Morrison HI, Hulka BS.

Fertil Steril. 1994 Jan;61(1):35-43.

PMID:
8293842
31.

32P-postlabeling analysis of DNA adducts in human sperm cells from smokers and nonsmokers.

Gallagher JE, Vine MF, Schramm MM, Lewtas J, George MH, Hulka BS, Everson RB.

Cancer Epidemiol Biomarkers Prev. 1993 Nov-Dec;2(6):581-5.

32.

Influence of biomarkers on the design, methods, and interpretation of epidemiologic studies.

Hulka BS, Garrett P.

J Toxicol Environ Health. 1993 Oct-Nov;40(2-3):389. No abstract available.

PMID:
7901426
33.

Cotinine concentrations in semen, urine, and blood of smokers and nonsmokers.

Vine MF, Hulka BS, Margolin BH, Truong YK, Hu PC, Schramm MM, Griffith JD, McCann M, Everson RB.

Am J Public Health. 1993 Sep;83(9):1335-8.

34.

Vitamin D and prostate cancer: a prediagnostic study with stored sera.

Corder EH, Guess HA, Hulka BS, Friedman GD, Sadler M, Vollmer RT, Lobaugh B, Drezner MK, Vogelman JH, Orentreich N.

Cancer Epidemiol Biomarkers Prev. 1993 Sep-Oct;2(5):467-72.

35.

HRAS protooncogene polymorphism and breast cancer.

Garrett PA, Hulka BS, Kim YL, Farber RA.

Cancer Epidemiol Biomarkers Prev. 1993 Mar-Apr;2(2):131-8.

36.

Use of exposure databases for status and trends analysis.

Goldman LR, Gomez M, Greenfield S, Hall L, Hulka BS, Kaye WE, Lybarger JA, McKenzie DH, Murphy RS, Wellington DG, et al.

Arch Environ Health. 1992 Nov-Dec;47(6):430-8.

PMID:
1485806
37.

Oral contraceptive use and cervical intraepithelial neoplasia.

Coker AL, McCann MF, Hulka BS, Walton LA.

J Clin Epidemiol. 1992 Oct;45(10):1111-8.

PMID:
1474407
38.

Active and passive cigarette smoke exposure and cervical intraepithelial neoplasia.

Coker AL, Rosenberg AJ, McCann MF, Hulka BS.

Cancer Epidemiol Biomarkers Prev. 1992 Jul-Aug;1(5):349-56.

39.

Does workplace health promotion decrease medical claims?

Wheat JR, Graney MJ, Shachtman RH, Ginn GL, Patrick DL, Hulka BS.

Am J Prev Med. 1992 Mar-Apr;8(2):110-4.

PMID:
1599718
40.

Methodological issues in epidemiologic studies using biologic markers.

Hulka BS, Margolin BH.

Am J Epidemiol. 1992 Jan 15;135(2):200-9. Review.

PMID:
1536135
41.

Barrier methods of contraception and cervical intraepithelial neoplasia.

Coker AL, Hulka BS, McCann MF, Walton LA.

Contraception. 1992 Jan;45(1):1-10.

PMID:
1591917
42.

Biomarkers of pesticide exposure.

Brewster MA, Hulka BS, Lavy TL.

Rev Environ Contam Toxicol. 1992;128:17-42. Review.

PMID:
1410687
43.

Nicotine and cotinine in the cervical mucus of smokers, passive smokers, and nonsmokers.

McCann MF, Irwin DE, Walton LA, Hulka BS, Morton JL, Axelrad CM.

Cancer Epidemiol Biomarkers Prev. 1992 Jan-Feb;1(2):125-9.

44.

ASPO Distinguished Achievement Award Lecture. Epidemiological studies using biological markers: issues for epidemiologists.

Hulka BS.

Cancer Epidemiol Biomarkers Prev. 1991 Nov-Dec;1(1):13-9. No abstract available.

45.

Oral contraceptives and breast cancer: a case-control study with hospital and community controls.

Schildkraut JM, Hulka BS, Wilkinson WE.

Obstet Gynecol. 1990 Sep;76(3 Pt 1):395-402.

PMID:
2381616
46.

Is vitamin D deficiency a risk factor for prostate cancer? (Hypothesis).

Schwartz GG, Hulka BS.

Anticancer Res. 1990 Sep-Oct;10(5A):1307-11.

PMID:
2241107
47.

Hormone-replacement therapy and the risk of breast cancer.

Hulka BS.

CA Cancer J Clin. 1990 Sep-Oct;40(5):289-96. Review.

48.

Principles of bladder cancer screening in an intervention trial.

Hulka BS.

J Occup Med. 1990 Sep;32(9):812-6.

PMID:
2074503
49.

Atypical metaplasia and incidence of bronchogenic carcinoma.

Vine MF, Schoenbach VJ, Hulka BS, Koch GG, Samsa G.

Am J Epidemiol. 1990 May;131(5):781-93.

PMID:
2321623
50.

Biochemical and biological markers: implications for epidemiologic studies.

Griffith J, Duncan RC, Hulka BS.

Arch Environ Health. 1989 Nov-Dec;44(6):375-81.

PMID:
2610525

Supplemental Content

Loading ...
Support Center